← Back to headlines
Regeneron and Sanofi's Dupixent Receives Label Expansion for Allergic Fungal Rhinosinusitis
Regeneron and Sanofi have announced that their drug Dupixent has received a label expansion, allowing it to be used for the treatment of allergic fungal rhinosinusitis.
24 Feb, 15:32 — 24 Feb, 15:32
ℹOnly 1 source covers this story
